NorthStar Node of the Clinical Trials Network

临床试验网络的 NorthStar 节点

• 批准号: 9408864
• 负责人: GAVIN BART
• 金额: $ 12.69万
• 依托单位: HENNEPIN HEALTHCARE RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-02-01 至 2018-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9408864
• 关键词: Accreditation; Adult; Alcohols; American; Behavioral; Caring; Chronic Care; Chronic Disease; Clinic; Clinical; Clinical Sciences; Clinical Trials Network; Collaborations; Communities; Community Outreach; Comorbidity; County; Development; Diabetes Mellitus; Disease; Disease Management; Electronic Health Record; Federally Qualified Health Center; Funding; Goals; Grant; HIV; Health; Health Maintenance Organizations; Health Services; Health Status; Health system; Healthcare; Healthcare Systems; Home environment; Hospitals; Inpatients; Institutes; Internal Medicine; Medical; Medical center; Medicine; Minnesota; Mission; Modeling; National Institute of Drug Abuse; Neurology; Opiates; Outpatients; Pain management; Patient Care Management; Patients; Pharmaceutical Preparations; Physicians; Population; Prevalence; Primary Health Care; Protocols documentation; Psychiatry; Recording of previous events; Research; Research Training; Residencies; Risk; Risk stratification; Schools; Science; Services; Student Health Services; Students; Substance Use Disorder; System; Time; Tobacco; Tobacco Use Cessation; Training; Translational Research; Translations; United States; Universities; Wellness Center; Withholding Treatment; addiction; behavioral health; binge drinking; burden of illness; chronic pain; economic cost; health care delivery; health care service utilization; health disparity; illicit drug use; innovation; medical specialties; prescription opiate; primary care setting; programs; public health relevance; safety net; smoking prevalence; success; support tools; tool; trauma centers; treatment program; university student

 DESCRIPTION: Substance use disorders (SUD) are significant contributors to the global burden of disease. Annual direct and indirect economic costs of alcohol, tobacco, and other drugs have been estimated at $500 billion in the United States alone. An estimated 20.2 million Americans are in need of treatment for a SUD, yet fewer than 5% receive specialty treatment. The most frequent point of health care contact in the United States is outpatient primary care. Minnesota ranks 1st in the US for health status and has one of the highest rates of access to primary care in the US. The proposed NorthStar node of the NIDA Clinical Trials Network brings together diverse healthcare delivery models that excel in delivery and research of primary care. Led by internal medicine physicians with practice and research expertise in addiction, the NorthStar node includes: 1) two major non-profit integrated health systems serving more than 1 million Minnesotans through over 100 primary care clinics (HealthPartners and Allina Health); 2) a Federally Qualified Health Center (NorthPoint Health & Wellness Center); 3) an accountable care organization managing the poorest and highest healthcare utilizing populations of Minnesota's most populous county (Hennepin Health); 4) a student health center, which provides primary and behavioral care for the more than 20,000 university students (University of Minnesota's Boynton Health Services); 5) the Institute for Clinical Systems Improvement (ICSI), a non-profit health improvement organization dedicated to developing and implementing quality improvement and best-practices protocols across more than 45 health systems and 8,000 physicians; and 6) the University of Minnesota Clinical and Translational Sciences Institute. In fulfillment of the CTN mission, the NorthStar node will develop (1) models of coordinated chronic care disease management of patients with SUD, (2) risk stratification tools for opiate prescription for chronic pain management in primary care, (3) clinical decision support tools focusing on the treatment of opiate use disorders, (4) integrated models of tobacco cessation treatment and HIV primary care, and (5) effective models to reduce 30-day readmission rates for SUD patients or at-risk users discharged from inpatient general medical settings.

 描述：物质使用障碍（SUD）是全球疾病负担的重要贡献者。仅在美国，酒精、烟草和其他药物每年造成的直接和间接经济成本就估计为5000亿美元。估计有2020万美国人需要治疗SUD，但只有不到5%的人接受专业治疗。在美国，最常见的卫生保健接触点是门诊初级保健。明尼苏达州的健康状况在美国排名第一，并且是美国获得初级保健的最高比率之一。NIDA临床试验网络的拟议北极星节点汇集了在初级保健提供和研究方面表现出色的各种医疗保健提供模式。由具有成瘾实践和研究专业知识的内科医生领导，北极星节点包括：1）两个主要的非营利性综合卫生系统，通过100多个初级保健诊所为100多万明尼苏达州人提供服务（HealthPartners和Allina Health）; 2）联邦合格的健康中心（NorthPoint Health & Wellness Center）; 3）一个负责任的护理组织，管理明尼苏达州人口最多的县中最贫穷和最高的医疗保健利用人口（Hennepin Health）; 4）学生健康中心，为20，000多名大学生提供初级和行为护理（明尼苏达大学博因顿健康服务）;临床系统改进研究所（ICSI）一个非营利性的健康改善组织，致力于在45个卫生系统和8 000名医生中制定和实施质量改善和最佳做法协议;明尼苏达大学临床和转化科学研究所。为实现CTN的使命，北极星节点将开发（1）SUD患者的协调慢性护理疾病管理模型，（2）初级护理中用于慢性疼痛管理的阿片类药物处方的风险分层工具，（3）侧重于治疗阿片类药物使用障碍的临床决策支持工具，（4）戒烟治疗和艾滋病毒初级护理的综合模型，和（5）有效的模式，以减少30天再入院率的SUD患者或有风险的用户出院的住院一般医疗设置。